metastatic renal cell carcinoma kokoke iaʻu

Ke ʻimi nei i ka Lapaʻau no ka Metastatic Renal Cell Carcinoma kokoke iā ʻoe

Hāʻawi kēia alakaʻi i ka ʻike piha no nā poʻe e ʻimi nei i ka lāʻau lapaʻau ka maʻi maʻi maʻi maʻi maʻi metastatic (mRCC) kokoke i ko lakou wahi. E uhi mākou i ka maʻi maʻi, nā koho lapaʻau, nā kumuwaiwai kākoʻo, a me nā mea koʻikoʻi e noʻonoʻo ai i ka wā e hoʻokele ai i kēia huakaʻi paʻakikī. ʻO ka hoʻomaopopo ʻana i kāu mau koho a me ke komo ʻana i ka mālama maikaʻi loa ka mea nui.

Hoʻomaopopo i ka Metastatic Renal Cell Carcinoma

He aha ka mRCC?

ʻO ka maʻi maʻi maʻi metastatic renal cell carcinoma he ʻano maʻi maʻi maʻi maʻi puʻupaʻa i laha mai ka puʻupaʻa i nā wahi ʻē aʻe o ke kino. He mea koʻikoʻi ka ʻike mua ʻana, no ka mea, hiki ke ʻokoʻa ka prognosis ma muli o ke ʻano o ka maʻi kanesa a me ka nui o ka metastasis. Hiki ke maʻalahi nā hōʻailona ma ka hoʻomaka ʻana, e komo pinepine i ke koko i loko o ka mimi, ka ʻeha o ka ʻaoʻao, a i ʻole ka palpable abdominal mass. ʻO kahi maʻi maʻamau e pili ana i nā hoʻokolohua kiʻi e like me CT scans, MRI scans, a me nā biopsies.

ʻO ke kūlana a me ka wānana

Hoʻoholo ka staging mRCC i ka nui o ka laha ʻana o ke kanesa. He mea koʻikoʻi kēia no ka hoʻolālā ʻana a me ka wānana. ʻO nā kumu e like me ka nui o ka maʻi maʻi mua, ke komo ʻana o nā ʻōpū lymph, a me ka loaʻa ʻana o nā metastases mamao e hoʻopili i ka pae a me ka wānana holoʻokoʻa. E kūkākūkā ana kāu kauka oncologist i kāu pae kikoʻī a me ke ʻano o kāu hoʻolālā lapaʻau.

Nā Koho Lapaʻau no ka mRCC

ʻO ka Lapaʻau Kūlohelohe

ʻO nā lāʻau lapaʻau i hoʻopaʻa ʻia he mau lāʻau i hoʻolālā ʻia e kuhikuhi pono i nā maʻi maʻi maʻi ʻoiai e hōʻemi ana i ka pōʻino i nā cell olakino. Loaʻa kekahi mau lāʻau lapaʻau i manaʻo ʻia no ka mRCC, me ka tyrosine kinase inhibitors (TKIs) e like me sunitinib, pazopanib, a me axitinib. Hiki i kēia mau lāʻau lapaʻau ke hoʻohaʻahaʻa maikaʻi i nā maʻi koko a hoʻomaikaʻi i nā helu ola. Na kāu kauka e hoʻoholo i ka lāʻau lapaʻau kūpono loa e pili ana i kou kūlana.

Immunotherapy

Hoʻohana ka Immunotherapy i ka mana o ke kino ponoʻī o ke kino e hakakā i ka maʻi kanesa. Hoʻohana pinepine ʻia nā mea hoʻopaʻapaʻa checkpoints, e like me nivolumab a me ipilimumab, i ka mālama ʻana i ka mRCC, ʻo ia wale nō a i hui pū ʻia me ka lāʻau lapaʻau. ʻO kēia mau lāʻau lapaʻau e kōkua i ka ʻōnaehana immune e ʻike a hoʻopau maikaʻi i nā maʻi kanesa. ʻOkoʻa ka hopena o ka immunotherapy ma muli o nā kumu pilikino.

ʻO ka ʻoki ʻana

He koho paha ka ʻokiʻoki ʻana no kekahi mau maʻi me ka mRCC, ʻoi aku ka nui o nā maʻi o ka maʻi kūloko a i ʻole ka pae ʻāina. Hiki i nā kaʻina hana o ke kaʻina hana ke hoʻoneʻe i ke kīkī i hoʻopilikia ʻia (nephrectomy) a i ʻole nā ​​ʻiʻo ʻē aʻe. ʻO ka hoʻoholo e pili ana i ka ʻoki ʻana e hilinaʻi ʻia i nā kumu like ʻole i loiloi ʻia e kāu kauka oncologist.

Lapaʻau Radiation

Hoʻohana ka lāʻau lapaʻau i ka pāhawewe ikaika nui e pepehi i nā maʻi maʻi maʻi. ʻOiai ʻaʻole pinepine ka lāʻau lapaʻau mua no ka mRCC, hiki ke hoʻohana ʻia e mālama i nā hōʻailona, ​​​​hoʻomaha i ka ʻeha, a mālama paha i nā wahi metastatic kikoʻī. Na kāu radiation oncologist e wehewehe i ke kūpono a me nā hopena ʻaoʻao o kēia lapaʻau i kāu hihia.

Nā hoʻokolohua lapaʻau

Hāʻawi ke komo ʻana i nā hoʻokolohua lapaʻau i ke komo ʻana i nā lāʻau lapaʻau hou a kōkua i ka holomua ʻana i ka noiʻi maʻi kanesa. Hiki i kāu kauka oncologist ke kūkākūkā i ka hiki ke hoʻopaʻa inoa i kahi hoʻokolohua lapaʻau kūpono, hiki ke hāʻawi i nā koho lapaʻau maikaʻi ʻaʻole i loaʻa ākea.

Ke ʻimi nei i ka mālama ma kahi kokoke iā ʻoe

Ke ʻimi nei i ka mālama maikaʻi no metastatic renal cell carcinoma he hana koʻikoʻi. E hoʻomaka me ka nīnau ʻana i kāu kauka mālama mua. Hiki iā lākou ke kuhikuhi iā ʻoe i nā loea e like me ka lāʻau lapaʻau oncologists, urologists, a me radiation oncologists i ʻike i ka mālama ʻana i ka maʻi maʻi maʻi. Nā kumuwaiwai pūnaewele, e like me ka National Cancer Institute (https://www.cancer.gov/) a me ka American Society of Clinical Oncology (https://www.asco.org/), hāʻawi i ka ʻike waiwai a hiki ke kōkua i ka ʻimi ʻana i nā loea ma kou wahi. Hiki iā ʻoe ke ʻimi ma ka pūnaewele no metastatic renal cell carcinoma kokoke iaʻu e huli i nā kikowaena lapaʻau ma kou kokoke. E noʻonoʻo i nā mea e like me ka ʻike o ka hui lapaʻau, ke komo ʻana i nā lāʻau lapaʻau kiʻekiʻe, a me kahi kokoke i kou home i ka wā e koho ai.

Kākoʻo a me nā kumuwaiwai

Ke alo nei i kahi hōʻailona o metastatic renal cell carcinoma hiki ke paʻakikī i ka naʻau. He mea nui ka ʻimi ʻana i ke kākoʻo mai ka ʻohana, nā hoaaloha, a me nā hui kākoʻo. ʻO nā hui e like me ka American Cancer Society (https://www.cancer.org/) hāʻawi i nā kumuwaiwai, nā mea hoʻonaʻauao, a me nā papahana kākoʻo no kēlā me kēia kanaka a me ko lākou ʻohana i loaʻa i ka maʻi kanesa. Mai hoʻokaʻulua e ʻimi aku i ke kōkua a e launa pū me nā poʻe ʻē aʻe e kū nei i nā huakaʻi like.

Hoʻolele

ʻO ka ʻike i hāʻawi ʻia ma kēia ʻatikala i manaʻo ʻia no ka ʻike ākea a me nā kumu ʻike wale nō, ʻaʻole ia he ʻōlelo aʻoaʻo olakino. E kūkākūkā mau me kekahi kauka lapaʻau kūpono no nā pilikia olakino a i ʻole ma mua o ka hoʻoholo ʻana e pili ana i kou olakino a lapaʻau paha. ʻAʻole pono e noʻonoʻo ʻia kēia ʻike he mea pani no ka ʻōlelo aʻoaʻo lapaʻau ʻoihana, ka maʻi maʻi, a i ʻole ka lāʻau lapaʻau.